News

News

Dr Marc Pellegrini and Dr Greg Ebert in the laboratory

Australian scientists have found a potential cure for hepatitis B virus (HBV) infections, with a promising new treatment proving 100 per cent successful in eliminating the infection in preclinical models.

21 April 2015
Malaria program staff

The Walter and Eliza Hall Institute’s quest to develop a vaccine for malaria received an $11.6 million boost in the latest National Health and Medical Research Council (NHMRC) funding announcement.

17 April 2015
Professor Doug Hilton in the lab

Walter and Eliza Hall Institute director Professor Doug Hilton has been named as one of 20 inaugural ‘Male Champions of Change’ by the Victorian Equal Opportunity and Human Rights Commission, for his work to improve the representation of women at senior levels of medical research.

15 April 2015
Tim Thomas and Anne Voss in the laboratory

Melbourne researchers have identified two key proteins that act as genetic ‘architects’, creating the blueprint needed by embryos during the earliest stages of their development.

14 April 2015
Dr Ian Street in the laboratory

Research to improve the lives of patients suffering from devastating blood diseases has received a $5.4 million boost from the Wellcome Trust.

9 April 2015
Dr Alex Delbridge and Dr Stephanie Grabow in the laboratory

Blocking key ‘survival’ proteins is a promising tactic for treating cancer, however new research suggests care should be taken as these proteins are also vital for emergency blood cell production.

7 April 2015
Researcher in a lab

The Walter and Eliza Hall Institute has been recognised by the National Health and Medical Research Council (NHMRC) for its contributions to innovative medical research that is used to improved patient care.

2 April 2015
Professor Andrew Roberts

Four Walter and Eliza Hall Institute researchers have tonight been recognised for their contributions to medical research, with their election as fellows of the newly established Australian Academy of Health and Medical Sciences.

25 March 2015
Dr Jason Tye-Din talks to the Coeliac Victoria and Tasmania group while a woman looks down a microscope

Coeliac Victoria and Tasmania today announced a $40,000 donation to support investigations into the under-researched area of childhood coeliac disease at the Walter and Eliza Hall Institute.

20 March 2015
Associate Professor Guillaume Lessene, Dr Ueli Nachbur and Professor Andrew Lew looking at a vial

Walter and Eliza Hall Institute scientists have developed a new drug-like molecule that can halt inflammation and has shown promise in preventing the progression of multiple sclerosis (MS).

17 March 2015

Pages